Across the state of Texas, antibody treatments for the immunocompromised called Evusheld are unused as there is a low request from providers. Debra Patt, M.D., PH.D., MBA, hematologist, medical oncologist, and executive vice president of Texas Oncology, explains how Evusheld can positively impact the lives of the immunocompromised.

This segment originally appeared on Spectrum News Austin: [ Ссылка ]#

свернуть